Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran

An overview of Iran's actions in response to the COVID-19 pandemic and in building health system resilience

(2023) Mohammad-Mehdi Gouya et al.   Frontiers in Public Health

The T cell immune response against SARS-CoV-2

(2022) Paul Moss   NATURE IMMUNOLOGY

Consecutive Waves of COVID-19 in Iran: Various Dimensions and Probable Causes

(2022) Mohammad Heidari et al.   Disaster Medicine and Public Health Preparedness

Innate immunological pathways in COVID-19 pathogenesis

(2022) Søren R. Paludan et al.   Science Immunology

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

(2022) Ainsley Ryan Yan Bin Lee et al.   BMJ-British Medical Journal

Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection

(2022) Samaneh Sajjadi et al.   GENE

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19

(2021) Linhua Tian et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

(2021) James M. Tesoriero et al.   JAMA Network Open

Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis

(2021) Paddy Ssentongo et al.   Scientific Reports

BNT162b2 COVID ‐19 vaccine is significantly less effective in patients with hematologic malignancies

(2021) Katrin Herzog Tzarfati et al.   AMERICAN JOURNAL OF HEMATOLOGY

SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1

(2021) Abelardo Araujo et al.   SEXUALLY TRANSMITTED INFECTIONS

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

(2021) Shabir A Madhi et al.   Lancet HIV

Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report

(2021) Olivera Lijeskić et al.   Vaccines

Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection

(2021) Yu Fu et al.   Vaccines

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis

(2021) Kevin Yau et al.   JAMA Network Open

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia

(2021) Naranjargal J. Dashdorj et al.   Cell Host & Microbe

An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates

(2021) Stephen Geoffrey Holt et al.   NEPHROLOGY

Human T leukaemia Type 1 and COVID-19

(2020) Abelardo Araujo et al.   Pathogens

Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent

(2020) Ashley Hirons et al.   LANCET INFECTIOUS DISEASES

COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far

(2020) Mujeeb Khan et al.   MOLECULES

Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies

(2019) Gill Schierhout et al.   LANCET INFECTIOUS DISEASES

HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment

(2017) Nicolas Futsch et al.   Viruses-Basel

HTLV-1, Immune Response and Autoimmunity

(2015) Juarez Quaresma et al.   Viruses-Basel

Epidemiology, Treatment, and Prevention of Human T-Cell Leukemia Virus Type 1-Associated Diseases

(2010) D. U. Goncalves et al.   CLINICAL MICROBIOLOGY REVIEWS